Business
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (&#...
About this update from Profound Medical Corp
[{"type":"text","content":"Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate TreatmentNew program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas\n\n\n\n TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) --\n \n Profound Medical Corp.\n \n (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free therapies for ablating diseased tissue, announced today the launch of a first-of-its-kind TULSA program by\n \n Texas Prostate\n \n and\n \n Dallas Medical Center\n \n to meet the growing demand for advanced prostate treatment — without surgery. Under the program, Texas Prostate will perform TULSA procedures for men with prostate cancer and benign prostatic hyperplasia (“BPH”) in Dallas Medical Center’s state-of-the-art MRI suite, significantly expanding Medicare patient access to the\n \n TULSA Procedure\n \n ™.\n \n\n “The TULSA procedure is integral to our practice because it offers many men effective prostate treatment without the life-altering side effects of surgery — such as incontinence or erectile dysfunction,” said Dr. James Cochran, founder of Texas Prostate. “With Medicare coverage now available, we’ve been seeking ways to offer more men access to this transformative technology. Working with Dallas Medical Center allows us to do just that.”\n \n\n In January,\n \n 2025 Medicare coverage was granted for the TULSA Procedure\n \n performed in Hospital Outpatient, Ambulatory Surgical Center and Private Office/Non-Facility settings, broadening access to the treatment. This collaboration makes the TULSA Procedure available under Medicare coverage, with Texas Prostate now performing TULSA procedures exclusively at Dallas Medical Center. The hospital gains both advanced technology and the Texas Prostate team’s proven expertise in performing TULSA Procedures.\n \n\n “At Dallas Medical Center, we’re committed to bringing advanced, compassionate care to our patients,” said Ruben Garza, CEO of Dallas Medical Center. “By working with Texas Prostate, patients can be treated with the TULSA-PRO\n \n...